Toby is a health economist with over 20 years’ experience in industry, academia, and strategic market access consultancy. He has extensive experience in developing HTA submissions, and in optimizing the use of evidence to support value propositions and overcome market access challenges.
Toby has held senior HEOR positions with a number of leading pharmaceutical companies, across therapy areas such as hemato-oncology, autoimmune disease, and neurology. Before joining PRMA Consulting, Toby owned an independent consultancy (Blue Gnu Consulting Ltd) providing HEOR expertise and strategic advice on HTA submissions and real-world data collection.
He holds a PhD in Health Economics from the University of Manchester.
Outside of work, Toby enjoys being out in the fresh air with his family, swimming, and cycling with friends.